Juqing Xu
Jiangsu Road, No.65
Nanjing, 210000, China
Nanjing, 210000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer.
Journal: Translational cancer research
Published: February 19, 2026
Nano-strategies targeting cancer-associated fibroblasts to enhance immunotherapy and reverse resistance.
Journal: Frontiers in immunology
Published: July 17, 2025
A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma.
Journal: Translational cancer research
Published: September 07, 2023
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction.
Journal: Journal of cancer research and clinical oncology
Published: August 17, 2023
Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer.
Journal: Cell reports. Medicine
Published: June 15, 2023
The prognostic value of COL3A1/FBN1/COL5A2/SPARC-mir-29a-3p-H19 associated ceRNA network in Gastric Cancer through bioinformatic exploration.
Journal: Journal of Cancer
Published: February 27, 2020
SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
Journal: Experimental and molecular pathology
Published: June 02, 2019
ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.
Journal: BioFactors (Oxford, England)
Published: September 29, 2018
CircRNF13 regulates the invasion and metastasis in lung adenocarcinoma by targeting miR-93-5p.
Journal: Gene
Published: February 19, 2018
COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 26, 2017
High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.
High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: November 25, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026